Evidence map›Paper›PMID 25647612›Full record

ArticlePLoS medicine2015

The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans.

Ming Zheng, Haili Zhang, David L Dill, J David Clark, Susan Tu, Arielle L Yablonovitch, Meng How Tan, Rui Zhang, Dan Rujescu, Manhong Wu and 10 more

Open access · goldAbstract read
In one paragraph

Article in PLoS medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Ming ZhengDepartment of Anesthesia, Stanford University School of Medicine, Stanford, California, United States of America.
Haili ZhangDepartment of Anesthesia, Stanford University School of Medicine, Stanford, California, United States of America.
David L DillComputer Science, Stanford University, Stanford, California, United States of America.
J David ClarkVeterans Affairs Palo Alto Health Care System, Palo Alto, California, United States of America.
Susan TuComputer Science, Stanford University, Stanford, California, United States of America.
Arielle L YablonovitchDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Meng How TanDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Rui ZhangDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Dan RujescuDepartment of Psychiatry, University Of Halle, Halle, Germany.
Manhong WuDepartment of Anesthesia, Stanford University School of Medicine, Stanford, California, United States of America.
Lino TessarolloCenter for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
Wilfred VieiraLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Michael M GottesmanLaboratory of Cell Biology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Suhua DengDepartment of Pathology, Stanford University, Stanford, California, United States of America.
Livia S EberlinDepartment of Chemistry, Stanford University, Stanford, California, United States of America.
Richard N ZareDepartment of Chemistry, Stanford University, Stanford, California, United States of America.
Jean-Martin BillardLaboratory of Molecular Cancer Biology, Molecular Physiology Research Unit (URPhyM), Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Belgium.
Jean-Pierre GilletLaboratory of Molecular Cancer Biology, Molecular Physiology Research Unit (URPhyM), Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Belgium.
Jin Billy LiDepartment of Genetics, Stanford University School of Medicine, Stanford, California, United States of America.
Gary PeltzDepartment of Anesthesia, Stanford University School of Medicine, Stanford, California, United States of America.
Stanford University · USNational Institutes of Health · USUniversity of Namur · BECenter for Cancer Research · USVA Palo Alto Health Care System · US

Funding

Genetic Analysis of the Multidrug Resistance Phenotype in Tumor CellsZIABC005598 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI GOTTESMAN, MICHAEL · 2009 to 2025
$11.9M
Gene Targeting FacilityZICBC011265 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI TESSAROLLO, LINO · 2010 to 2025
$8.9M
Molecular Biophysics Training Program at StanfordT32GM008294 · NIGMS · STANFORD UNIVERSITY · PI HUANG, KERWYN C. · 1989 to 2019
$7.4M
Human Pharmacogenetics and Human Liver RegenerationR01DK090992 · NIDDK · STANFORD UNIVERSITY · PI PELTZ, GARY A · 2010 to 2014
$6.4M
NIDDK NIH HHS 1R01DK090992-01NIDDK NIH HHS R01 DK090992NIGMS NIH HHS T32 GM008294
6 · The paper itself

Abstract

backgroundWe know very little about the genetic factors affecting susceptibility to drug-induced central nervous system (CNS) toxicities, and this has limited our ability to optimally utilize existing drugs or to develop new drugs for CNS disorders. For example, haloperidol is a potent dopamine antagonist that is used to treat psychotic disorders, but 50% of treated patients develop characteristic extrapyramidal symptoms caused by haloperidol-induced toxicity (HIT), which limits its clinical utility. We do not have any information about the genetic factors affecting this drug-induced toxicity. HIT in humans is directly mirrored in a murine genetic model, where inbred mouse strains are differentially susceptible to HIT. Therefore, we genetically analyzed this murine model and performed a translational human genetic association study. METHODS AND

findingsA whole genome SNP database and computational genetic mapping were used to analyze the murine genetic model of HIT. Guided by the mouse genetic analysis, we demonstrate that genetic variation within an ABC-drug efflux transporter (Abcb5) affected susceptibility to HIT. In situ hybridization results reveal that Abcb5 is expressed in brain capillaries, and by cerebellar Purkinje cells. We also analyzed chromosome substitution strains, imaged haloperidol abundance in brain tissue sections and directly measured haloperidol (and its metabolite) levels in brain, and characterized Abcb5 knockout mice. Our results demonstrate that Abcb5 is part of the blood-brain barrier; it affects susceptibility to HIT by altering the brain concentration of haloperidol. Moreover, a genetic association study in a haloperidol-treated human cohort indicates that human ABCB5 alleles had a time-dependent effect on susceptibility to individual and combined measures of HIT. Abcb5 alleles are pharmacogenetic factors that affect susceptibility to HIT, but it is likely that additional pharmacogenetic susceptibility factors will be discovered.

conclusionsABCB5 alleles alter susceptibility to HIT in mouse and humans. This discovery leads to a new model that (at least in part) explains inter-individual differences in susceptibility to a drug-induced CNS toxicity.

Indexed as

AllelesPolymorphism, Single NucleotideAdolescentAdultAnimalsAntipsychotic AgentsATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Blood-Brain BarrierBrainFemaleGenetic Association StudiesGenetic Predisposition to DiseaseHaloperidolHumansABCB5 protein, humanABCB5 protein, mouseAntipsychotic AgentsATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily BATP Binding Cassette Transporter, Subfamily B, Member 1Haloperidol

Identifiers

PMID25647612
PMCPMC4315575
OpenAlexW1985272560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.